18[F]FDG-PET/CT is a Useful Molecular Marker in Evaluating Tumour Aggressiveness: A Revised Understanding of an In-Vivo FDG-PET Imaging that Alludes the Alteration of Cancer Biology
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
18[F]FDG-PET/CT is a Useful Molecular Marker in Evaluating Tumour Aggressiveness: A Revised Understanding of an In-Vivo FDG-PET Imaging that Alludes the Alteration of Cancer Biology
Authors
Keywords
In vivo, <sup>18</sup>[F]FDG-PET/CT, Tumour aggressiveness, Molecular marker, Tumour biology
Journal
CELL BIOCHEMISTRY AND BIOPHYSICS
Volume 66, Issue 1, Pages 37-43
Publisher
Springer Nature
Online
2012-07-11
DOI
10.1007/s12013-012-9395-5
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- 18F-FDG PET/CT for Early Response Assessment in Diffuse Large B-Cell Lymphoma: Poor Predictive Value of International Harmonization Project Interpretation
- (2011) A. F. Cashen et al. JOURNAL OF NUCLEAR MEDICINE
- VEGF-A and its isoform VEGF121 mRNA expression measured by quantitative real-time RT-PCR: correlation with F-18 FDG uptake and aggressiveness of lung adenocarcinoma: preliminary study
- (2010) JianFei Guo et al. ANNALS OF NUCLEAR MEDICINE
- 18F-Fluorodeoxyglucose Positron Emission Tomography Predicts Survival of Patients with Neuroendocrine Tumors
- (2010) T. Binderup et al. CLINICAL CANCER RESEARCH
- The association of 18F-deoxyglucose (FDG) uptake of PET with polymorphisms in the glucose transporter gene (SLC2A1) and hypoxia-related genes (HIF1A, VEGFA, APEX1) in non-small cell lung cancer. SLC2A1 polymorphisms and FDG-PET in NSCLC patients
- (2010) Seong-Jang Kim et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Positron Emission Tomography/Computed Tomography and Lymphovascular Invasion Predict Recurrence in Stage I Lung Cancers
- (2010) Satoshi Shiono et al. Journal of Thoracic Oncology
- PET-CT in Radiation Oncology
- (2009) Dwight E. Heron et al. AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS
- Fluorodeoxyglucose positron emission tomography and tumor marker expression in non–small cell lung cancer
- (2009) Matthew D. Taylor et al. JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY
- Comparison of 18F-FDG, 18F-FET and 18F-FLT for differentiation between tumor and inflammation in rats
- (2009) Tae Sup Lee et al. NUCLEAR MEDICINE AND BIOLOGY
- Correlation of 18F-FDG PET activity with expressions of survivin, Ki67, and CD34 in non-small-cell lung cancer
- (2009) Bo Han et al. NUCLEAR MEDICINE COMMUNICATIONS
- Glucose Deprivation Contributes to the Development of KRAS Pathway Mutations in Tumor Cells
- (2009) J. Yun et al. SCIENCE
- Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation
- (2009) M. G. Vander Heiden et al. SCIENCE
- Tumor Cell Metabolism: Cancer's Achilles' Heel
- (2008) Guido Kroemer et al. CANCER CELL
- Epigenetic-Genetic Interactions in the APC/WNT, RAS/RAF, and P53 Pathways in Colorectal Carcinoma
- (2008) Y. Suehiro et al. CLINICAL CANCER RESEARCH
- FDG uptake, a surrogate of tumour hypoxia?
- (2008) Rudi Andre Dierckx et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Relation between nodule size and 18F-FDG-PET SUV for malignant and benign pulmonary nodules.
- (2008) Majid Khalaf et al. Journal of Hematology & Oncology
- Prospective Comparison of FDG and FET PET/CT in Patients with Head and Neck Squamous Cell Carcinoma
- (2008) S. Balogova et al. MOLECULAR IMAGING AND BIOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started